Ro KhannaBuy
BAX Common Stock · Transaction May 27, 2026 · Filed Jun 9, 2026 · Amount pending receipt enrichment
NEW YORK STOCK EXCHANGE, INC. · BAX
+0.35% · +$0.0900 · Vol Not reported
Pre-market · updated 05:08:35 ET
Baxter International Inc
Health Care
$26.00
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · BAX
MethodologyBAX
Baxter International Inc
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
72/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BAX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Baxter International Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
1961
Employees
38K
Country
US
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$25.91
Last session
Day high
$25.91
Last session
Day low
$25.91
Last session
Previous close
$25.91
52W high
$28.35
-8.29% from high
52W low
$15.80
81% of range
Market cap
$13.8B
P/E
44.83×
EPS
$0.5800
Beta
0.77
Shares out
517M
Avg volume
7.1M
VWAP
$25.91
Last session
Price history computed in-house
1W
-5.83%
1M
+14.99%
3M
+38.52%
1Y
+10.12%
YTD
+36.05%
SMA 50 $23.08 · above
SMA 200 $19.82 · above
52W position 81%
BAX overview
Related filings and maps
Public disclosures
Congress activity in BAX
Official filing ↗
Ro KhannaBuy
BAX Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · Amount pending receipt enrichment
Ro KhannaBuy
BAX Common Stock · Transaction May 1, 2026 · Filed Jun 9, 2026 · Amount pending receipt enrichment
Ro KhannaSell
BAX Common Stock · Transaction Apr 24, 2026 · Filed May 11, 2026 · Amount pending receipt enrichment
Ro KhannaSell
BAX Common Stock · Transaction Apr 13, 2026 · Filed May 11, 2026 · Amount pending receipt enrichment
Federal contracts
BAX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BAX in this window.
Lobbying spend
BAX lobbying filings, year to date.
Registered lobbying filings matched to Baxter International Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BAX in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for BAX.
Options
Sovereign unlock shows live options positioning for BAX.